{
    "code": 0,
    "data": [
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith transcript of the earnings call held on February 04 2026.",
            "news_id": "0716d0a0-92d8-4e36-8f74-0b0eafb02747",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=180ea216-6a53-4636-ab60-29dd53fac631.pdf",
            "news_date": "2026-02-07 16:29:40",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find enclosed herewith audio recording of earnings call held on February 04 2026.",
            "news_id": "3ae747ad-348f-459e-bd0e-f745d098fbbd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcea7cd5-3b2f-4b34-b2c9-8f7821638d4b.pdf",
            "news_date": "2026-02-04 18:30:56",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter and nine months ended December 31 2025",
            "news_id": "774e001a-5cc7-45ba-a008-5e6576a07728",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c354304-ec2f-4ebe-82ed-74a8a9f086c1.pdf",
            "news_date": "2026-01-31 15:12:19",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Advanced Enzyme Technologies Limited has informed the Exchange about the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months  ended December 31 2025",
            "news_id": "ec7c8d32-1612-4db8-99f7-f797caffdcd1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aaf65f4e-7c7e-46c8-93e6-b8ad49eb3969.pdf",
            "news_date": "2026-01-31 12:47:21",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith transcript of the earnings conference call held on November 12 2025.",
            "news_id": "21d976fa-f0c2-4913-9b49-a8567c8612c6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98f9af2e-9e6f-4756-89f4-1de7b2a1585d.pdf",
            "news_date": "2025-11-17 16:30:13",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Conference Call for the Un-audited Financial Results for the quarter and half year ended September 30 2025",
            "news_id": "2a838dc0-1443-4854-8969-ef8359edf3ca",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0cf7c856-3d15-451c-8433-40dd82060157.pdf",
            "news_date": "2025-11-13 18:44:46",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the Quarter and Half year ended September 30 2025",
            "news_id": "34f7353c-a475-4106-937e-3b2e341b8332",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cddf073-491e-4bdf-907a-5c5e21684dee.pdf",
            "news_date": "2025-11-12 17:02:10",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Financial Results For Quarter And Half Year Ended September 30 2025",
            "news_body": "Please find enclosed herewith Standalone and Consolidated Financial Results for Quarter and Half Year ended September 30 2025",
            "news_id": "8bfe5d15-6708-4a4d-b78a-acf77cc73c93",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4de6c86b-6731-490d-9bb2-1d0812ee0915.pdf",
            "news_date": "2025-11-12 10:33:38",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith Investor Presentation for the Pharma and Healthcare Conference to be held on 23-09-2025.",
            "news_id": "05ceb03f-fcc6-495c-a30c-51dcd2a10759",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62c3a31a-e1de-4aa3-863b-d598a0d55844.pdf",
            "news_date": "2025-09-22 14:14:59",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Conference call held on Wednesday August 06 2025 with Analysts and Investors for the Un-audited Financial Results of the Company for the Quarter ended June 30 2025",
            "news_id": "5fbc6032-5828-453f-ac80-e2693f6f465c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=791b6684-0467-4aec-b40f-d153e38e279c.pdf",
            "news_date": "2025-08-11 18:47:46",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Conference Call for the Un-audited Financial Results for the quarter ended June 30 2025",
            "news_id": "1278bf25-c8a9-4e40-9972-b66b25135ac0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0488ec55-2e27-4e3a-b106-488ff695c9b6.pdf",
            "news_date": "2025-08-06 18:45:51",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the Quarter ended June 30 2025",
            "news_id": "273cecdb-84cf-4c46-8ac9-fb99344c7252",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6926ddae-87f0-461d-84f9-b39a39161b6d.pdf",
            "news_date": "2025-08-02 15:19:14",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30 2025",
            "news_body": "The Board of Directors at its Meeting held on August 02 2025 approved Unaudited Financial Results (Standalone & Consolidated) for the Quarter ended June 30 2025 along with Limited Review Report issued by MSKA & Associates Statutory Auditors of the Company",
            "news_id": "ca7e1d57-5ab5-416c-a6f1-4ac8dbee3d3a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9520edd-4fae-403e-bc54-86b5396d6ea1.pdf",
            "news_date": "2025-08-02 12:58:59",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimated letter dated May 09 2025 please find enclosed the Transcript of the Conference call held on Wednesday May 14 2025 with Analysts and Investors for the audited Financial Results of the Company for the quarter and year ended March 31 2025",
            "news_id": "0db87b7b-ebf2-401e-aea8-b8e342d6629a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4560608f-45b8-45c5-8573-e1c4c965cc63.pdf",
            "news_date": "2025-05-19 12:18:33",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (as amended) the audio recording of the Conference call held today i.e. on Wednesday May 14 2025 on the audited Financial Results for the quarter and year ended March 31 2025 is available on the website of the Company at www.advancedenzymes.com/investors/analyst-corner",
            "news_id": "9fdb799b-ef86-4538-807a-58087095d3ff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83ae2855-c1e8-4d68-aad5-b51a73ec0127.pdf",
            "news_date": "2025-05-14 17:57:47",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation for quarter and year ended March 31 2025.",
            "news_id": "de52f7aa-6a6c-4e0b-80a7-d2eeed83872c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=711f2bd9-953a-4024-8e43-5c987169e560.pdf",
            "news_date": "2025-05-13 19:00:52",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Results For FY 2024-25",
            "news_body": "Refer attached file.",
            "news_id": "d4aa0193-febc-44db-838f-6615e7cb0c43",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e957cb9-46d1-447d-be2b-5079dcf90b37.pdf",
            "news_date": "2025-05-13 12:29:09",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In futherance to our intimation letter dated February 03 2025 please find enclosed the Transcript of the Conference Call held on Wednesday February 12 2025 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter and nine months ended December 31 2024.\r\n\r\nThe aforesaid information is also being uploded on the website of the Company",
            "news_id": "52577e53-6ccb-4cd5-946d-6cdc77d95259",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e589c260-74b6-4f8c-b2a8-59f244d6646c.pdf",
            "news_date": "2025-02-17 14:32:06",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earning Presentation- Third Quarter FY2024-25",
            "news_id": "18c1c664-558b-4a34-ae35-642d603e1d23",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ceeeff9-94ba-48db-8f39-70eb44eb95a6.pdf",
            "news_date": "2025-02-08 21:20:04",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "Advanced Enzyme Technologies Limited has informed the Exchange about the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quater and nine months ended December 31 2024\r\n\r\nThe aforesaid financial results are also being uploaded on the website of the Company i.e. www.advancedenzymes.com",
            "news_id": "e1bf5d21-6ddd-4878-981e-5285794a7869",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64cda602-363d-4682-8a8a-55df1f381f4f.pdf",
            "news_date": "2025-02-08 12:50:48",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Conference Call held on Wednesday, November 13, 2024 with Analysts and Investors for the Un-audited Financial Results of the Company for the quarter and half year ended September 30, 2024",
            "news_id": "4c2b59be-170e-4cec-850f-f3339fd0f93f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c75e7ab-ee58-4811-91a5-b4cc0acadff5.pdf",
            "news_date": "2024-11-19 12:46:41",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Conference Call for the Un-audited Financial Results for the quarter and half year ended September 30, 2024",
            "news_id": "52594091-3f65-4d38-84c2-ea1b9596c403",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1b22f0e-ba0e-40f1-8895-f005c09b8a23.pdf",
            "news_date": "2024-11-13 18:12:12",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter and half year ended September 30, 2024",
            "news_id": "7d7663c8-ba9c-4ca3-9abe-656ebd8d0577",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3a15dbe-f8b6-498a-84dd-51d08b919e78.pdf",
            "news_date": "2024-11-09 14:57:09",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On November 09, 2024",
            "news_body": "Un-audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Haly year ended September 30, 2024",
            "news_id": "3cb99aa2-cee9-4f67-82b7-838b3a373ecc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d54dbb2-3984-41df-919c-409a123ee6b5.pdf",
            "news_date": "2024-11-09 10:56:46",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On November 09, 2024",
            "news_body": "With reference to the notice of Board Meeting dated November 09, 2024, we hereby inform that the Board of Directors at its Meeting held on November 09, 2024 has inter-alia approved the Unaudited Financial Results (Standalone & Consolidated ) of the Company for the quarter and half year ended September 30, 2024",
            "news_id": "7791dcb2-6e24-4aca-acc9-36de05faf99b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a1e0922-6e89-4910-bc42-d9d726acb56b.pdf",
            "news_date": "2024-11-09 10:52:45",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording - Conference Call - Un-audited Financial Results for the quarter ended June 30, 2024",
            "news_id": "de50e64d-74fc-48ab-a4ea-f0a8b904b7a0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=645fbac8-22b4-40ff-b79f-a4929fc9d54b.pdf",
            "news_date": "2024-08-13 18:19:38",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the Quarter ended June 30, 2024",
            "news_id": "0a544841-8772-4dc9-9e27-fe3de015d3c9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2d34c4f-043b-42f5-a280-f5e4bcbe329f.pdf",
            "news_date": "2024-08-10 15:39:48",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Statement Of Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2024",
            "news_body": "Un-Audited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2024",
            "news_id": "b89c406e-6492-4cf6-a2b9-baa46735dd2b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5058de09-a7cc-4b2d-9e07-6b309a32aadd.pdf",
            "news_date": "2024-08-10 11:16:55",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Conference Call held on Wednesday, May 15, 2024 with Analysts and Investors for the auidted Financial Results of the Company for quarter and year ended March 31, 2024",
            "news_id": "3af42deb-21e6-49dd-995b-4ecae532c0f0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7bbd7851-d460-4af9-ab19-5fbc14c339e9.pdf",
            "news_date": "2024-05-21 17:31:33",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), the audio recording of the Conference call held today i.e. on Wednesday, May 15, 2024 on the audited Financial Results for the quarter and year ended March 31, 2024, is available on the website of the Company at www.advancedenzymes.com/investors/analyst-corner",
            "news_id": "4c5a0615-35c4-4fa9-b952-723952ab2490",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b83305e5-7df2-46ca-b2f4-99f1679e391a.pdf",
            "news_date": "2024-05-15 18:20:20",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015. enclosed is Earning Presentation for the quarter and year ended March 31, 2024",
            "news_id": "89cc1ec8-c4b0-4b7e-829d-c0a24646fb34",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=699fe136-4fe5-4cd3-9b3b-e111d1c608b3.pdf",
            "news_date": "2024-05-11 18:12:29",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Statement (Standalone And Consolidated) Of The Company For The Financial Year Ended March 31, 2024",
            "news_body": "Audited Financial Statement (Standalone and Consolidated)of the Company for the Financial year ended March 31, 2024",
            "news_id": "53510534-f506-4806-b53f-013698377058",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea5e0230-261a-4aa0-9bc3-4fb88c2f5bd0.pdf",
            "news_date": "2024-05-11 13:40:51",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimation letter dated February 10, 2024, please find enclosed the Transcript of the Conference call held on Friday, February 16, 2024 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter and nine months ended December 31, 2023",
            "news_id": "b927e867-ce5e-4207-a319-0f56fd961f79",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=addcd500-fbd6-48cb-b321-cd591ff15a4d.pdf",
            "news_date": "2024-02-21 12:23:55",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of conference call held today",
            "news_id": "e0e6f1cb-ca07-4ef4-b632-2a6653e290ef",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02db4abf-a3db-4e9f-8b44-80d557cefae4.pdf",
            "news_date": "2024-02-16 18:22:17",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter and nine months ended December 31, 2023",
            "news_id": "008abc72-5987-4bcd-98bc-17004f448335",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7d061d9-421a-41c6-a004-93fd85d6775e.pdf",
            "news_date": "2024-02-10 16:28:30",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Statement Of Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2023",
            "news_id": "1f757075-4637-40a7-b437-2aebe903b4e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fd9acf7-8038-48b6-ba54-72c34ad6a6f8.pdf",
            "news_date": "2024-02-10 12:41:32",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimation letter dated November 01, 2023, Please find enclosed the Transcript of the Conference call held on Friday, November 10, 2023 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter and half year ended September 30, 2023.",
            "news_id": "a7b1a411-f14d-437d-8fba-459c8f46650d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d03babb-435b-46dc-8361-9e3c8557dbd3.pdf",
            "news_date": "2023-11-17 14:58:37",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), the audio recording of the Conference call held on Friday, November 10, 2023 on the Un-audited Financial Results for the quarter and half year ended September 30, 2023, is available on the Company's website at https://www.advancedenzymes.com/investors/analyst-corner",
            "news_id": "f8336c21-8660-44ff-83a4-b5f6d47f3df1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd062ab0-5e9d-4a7a-ab31-39c8b97276ef.pdf",
            "news_date": "2023-11-11 10:18:13",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter and half year ended September 30, 2023",
            "news_id": "81d30723-9c47-47e3-b119-900e3817b5ba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=172c00c1-51ba-45d1-914a-e456d48e450d.pdf",
            "news_date": "2023-11-07 16:21:07",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On November 07, 2023",
            "news_body": "Outcome of Board Meeting held on November 07, 2023",
            "news_id": "1e20e802-191d-4326-8fa0-82315b42a799",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=192f4409-7ee7-4ad6-8d8c-4c011f642325.pdf",
            "news_date": "2023-11-07 12:25:47",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On November 07, 2023",
            "news_body": "with reference to the notice of Board Meeting dated October 31, 2023, we hereby inform that the Board of Directors at its Meeting held on November 07, 2023 has inter-alia approved the unaudited financial results (Standalone & Consolidated ) of the Company for the quarter and half year ended September 30, 2023.",
            "news_id": "10e3827b-520b-4a85-938f-556f5d1c7628",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09667154-ade7-4911-ac37-7db234b155e6.pdf",
            "news_date": "2023-11-07 12:22:43",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On November 07, 2023",
            "news_body": "With reference to the notice of Board Meeting dated October 31, 2023, we hereby inform that the Board of Directors at its Meeting held on November 07, 2023 (commenced at 11.25 a.m. and concluded at 11.55 a.m.) has inter alia, approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2023.<BR> <BR> In view of the aforesaid, we are enclosing Annexure I - Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2023 along with the Limited Review report issued by MSKA & Associates, Statutory Auditors of the Company as an Annexure.<BR> <BR> The aforesaid financial results and other documents are also being uploaded on the website of the Company i.e. www.advancedenzymes.com<BR> <BR> This is for your information and for public at large.<BR>",
            "news_id": "d1925ff1-3783-43f4-9ba1-07f8bea29c36",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a557244-6567-4289-a211-39f75a22ef7d.pdf",
            "news_date": "2023-11-07 12:13:45",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In futherance to our intimation letter dated August 07, 2023, please find enclosed the Transcript of the Conference Call held on Wednesday, August 16, 2023 with Analyst and Investors for the un-audited Financial Results of the Company for the quarter ended June 30, 2023",
            "news_id": "ecb5355b-891c-4170-87d8-bf86bbd86fd5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0164793f-273e-4cae-be8d-33bca752dd43.pdf",
            "news_date": "2023-08-23 10:12:01",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), the audio recording of the Conference call held today i.e. on Wednesday, August 16, 2023 on the Un-audited Financial Results for the quarter ended June 30, 2023, is available on the Company's website at https://www.advancedenzymes.com/investors/analyst-corner",
            "news_id": "57c29ed6-8cbf-4c83-bdbd-c16de0a58266",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5aec0faa-533e-4d4a-b06f-5633a669682b.pdf",
            "news_date": "2023-08-16 18:46:24",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earning Presentation for the quarter ended June 30, 2023",
            "news_id": "fec10d2e-fff0-4f86-b470-5879ac672394",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b23663f-4800-4d9d-93a4-fa42bf64a677.pdf",
            "news_date": "2023-08-12 13:11:19",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Statement Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended 30Th June, 2023",
            "news_body": "Statement of Unaudited Standalone and Consolidated Financial Results of the Company for the Quater ended 30th June 2023",
            "news_id": "f56b9b43-a761-4bd2-99af-614711593e47",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f63ecc33-c25e-4745-9c2d-9b36ed6e1962.pdf",
            "news_date": "2023-08-12 11:12:17",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimation letter dated May 12, 2023, please find enclosed the Transcript of the Conference call held on Monday, May 15, 2023 with Analysts and Investors for the audited Financial Results of the Company for the quarter and year ended March 31, 2023.",
            "news_id": "55f027a5-a2af-4fa6-9c43-110907cb57d5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fe70be3-699d-441d-8b5b-9b091cd1f148.pdf",
            "news_date": "2023-05-18 16:56:25",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), the audio recording of theConference call held today i.e. on Monday, May 15, 2023 on the audited Financial Results for the quarter and year ended March 31, 2023, is available on the website of the Company at https://www.advancedenzymes.com/investors/analyst-corner",
            "news_id": "38e9ecb2-b6e4-46ef-9fb6-03a8ccb9f657",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ece76a0-8de0-4e7f-9896-f75427bbd0a3.pdf",
            "news_date": "2023-05-15 19:12:44",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is Earnings Presentation for the quarter and yearended March 31, 2023.",
            "news_id": "68d6d128-bad3-4768-abfd-46aacbbc38ec",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=acb29140-0ad6-48e5-9507-3aa1d0536bf7.pdf",
            "news_date": "2023-05-13 16:36:52",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended March 31, 2023",
            "news_body": "Advanced Enzyme Technologies Limited has informed the Exchange about the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2023 along with the Auditor''s Report issued by MSKA & Associates, Statutory Auditors of the CompanyThe aforesaid financial results and other documents are also being uploaded on the website of the Company i.e. www.advancedenzymes.com",
            "news_id": "8f6f0f12-0a1c-4ad6-9f50-dd3e26d3f238",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57323751-f807-4b08-ab4d-2853a90dcb06.pdf",
            "news_date": "2023-05-13 13:29:00",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Furtherance to our intimation letter dated February 07, 2023, please find enclosed the Transcript of the Conference call held on Tuesday, February 14, 2023 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter and nine months ended December 31, 2022.",
            "news_id": "0f4099fc-a3c3-4024-8103-a493d1a0fe12",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4173f2db-a938-42df-8500-bdf52dee65ea.pdf",
            "news_date": "2023-02-17 20:16:42",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Conference call held today i.e. on Tuesday, February 14, 2023 on the Un-audited Financial Results for the quarter and nine months ended December 31, 2022",
            "news_id": "61239bff-edb1-4208-abd1-72a4dd1e2575",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d952fd2-f2a3-4ecf-9c66-b21172f467d0.pdf",
            "news_date": "2023-02-14 17:41:33",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter ended December 31, 2022",
            "news_id": "0281088f-ba82-4428-908a-3816a4c55346",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f869463-731f-45ef-aa94-2d3f6b9458e6.pdf",
            "news_date": "2023-02-11 14:54:33",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On February 11, 2023",
            "news_body": "With reference to the notice of Board Meeting dated February 04, 2023, we hereby inform that the Board of Directors of the Company at its meeting held on February 11, 2023 (commenced at 11.25 a.m. and concluded at 12.10 p.m.) has inter alia, transacted the following business: <BR> <BR> Approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2022.<BR> <BR> Approved the allotment of 2,000 Equity Shares of face value of Rs. 2/- at an exercise price of  Rs. 60/- per share pursuant to exercise of options under the Employees Stock Option Scheme, 2015.<BR> <BR> In view of the aforesaid, we are enclosing the following:<BR> Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2022 along with the Limited Review report issued by MSKA & Associates, Statutory Auditors of the Company, as Annexure I to this letter.<BR> <BR> This is for your information and for public at large. <BR>",
            "news_id": "14ee07bf-cdca-491c-8638-0b672ac6a1cb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec997bf5-4c23-4631-9097-e1597e68ecdc.pdf",
            "news_date": "2023-02-11 12:18:14",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Under Regulation 23(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Details OfRelated Party Transactions.",
            "news_body": "Pursuant to the provisions of Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the relevant disclosure on Related Party Transactions for the half year ended September 30, 2022, in the format specified under the SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021.",
            "news_id": "b27af0f9-ff7d-4fed-881a-11a71d9a0b28",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bcb64271-9ff1-42e9-bb39-a512f57a43af.pdf",
            "news_date": "2022-11-25 12:50:45",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Furtherance to our intimation letter dated November 08, 2022, please find enclosed the Transcript of the Conference call held on Tuesday, November 15, 2022 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter and half year ended September 30, 2022.",
            "news_id": "e5bb2d45-ad50-4399-a3af-c0e012ba1ff0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5cec976a-063d-4d29-b2b9-f549a09a8a57.pdf",
            "news_date": "2022-11-21 12:31:47",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Conference call held today i.e. on Tuesday, November 15, 2022 on the Un-audited Financial Results for the quarter and half year ended September 30, 2022",
            "news_id": "69d8db3a-e230-4fa0-b14c-75562eacf07a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7aa204f-544b-42ae-9e84-8c877d134b2c.pdf",
            "news_date": "2022-11-15 18:53:25",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter ended September 30, 2022",
            "news_id": "f792b80e-bfcf-4b4c-9957-c5e7ece885a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=780e07ca-6420-4b81-bc09-41b7d72a629c.pdf",
            "news_date": "2022-11-11 17:33:18",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On November 11, 2022",
            "news_body": "With reference to the Board meeting notice dated November 04, 2022, we hereby inform that the Board of Directors in its meeting held on November 11, 2022 (commenced at 11:15 a.m. and concluded at 12:15 p.m.) has inter-alia, approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter and half year ended September 30, 2022.<BR> <BR> In view of the aforesaid, we hereby enclose the following:<BR> <BR> Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2022 along with the Limited Review Report issued by M S K A & Associates, Statutory Auditors of the Company.<BR> This is for your information and for public at large.<BR>",
            "news_id": "3933d36b-c499-4fb6-8921-5e1600564640",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8b04e14-3017-4db0-a146-f39956dfa5a3.pdf",
            "news_date": "2022-11-11 12:39:14",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Furtherance to our intimation letter dated August 02, 2022, please find enclosed the Transcript of the Conference call held on Saturday, August 06, 2022 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter ended June 30,2022.",
            "news_id": "7d4cab1a-6915-4b10-845f-5c4d556ee962",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd2f8ce1-a27c-45f5-b893-fdaad319599e.pdf",
            "news_date": "2022-08-09 13:56:34",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter ended June 30, 2022",
            "news_id": "957ca8e7-6adb-472d-af49-0c2842325f89",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79dfaea4-83e1-45dd-a69d-5dc8d6ef4f90.pdf",
            "news_date": "2022-08-06 13:02:51",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results Of The Company (Standalone And Consolidated) For The Quarter Ended June 30, 2022",
            "news_body": "With reference to the Board meeting notice dated July 30, 2022, we hereby inform that the Board of Directors in its meeting held on August 06, 2022 (commenced at 10:00 a.m. and concluded at 10:45 a.m.) has inter-alia, approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter ended June 30, 2022.<BR> <BR> In view of the aforesaid, we hereby enclose the following:<BR> Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2022 along with the Limited Review Report issued by M S K A & Associates, Statutory Auditors of the Company.<BR> <BR> This is for your information and for public at large.<BR>",
            "news_id": "9a1060e4-6132-4213-841f-c1cb1e9c94fb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71f4d7f9-72ed-406b-b758-1bfb22a598ef.pdf",
            "news_date": "2022-08-06 10:58:45",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2022",
            "news_body": "Pursuant to the provisions of Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the relevant disclosure on Related Party Transactions of the Company in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021, for the half year ended March 31, 2022.",
            "news_id": "3e2edb18-ba05-4c08-b425-3ba5d11c6cb5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db5ae33c-fe3b-4ca8-aac6-745c2b7b7fb6.pdf",
            "news_date": "2022-06-03 19:25:29",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimation letter dated May 17, 2022, please find enclosed the Transcript of the Conference call held on Monday, May 23, 2022 with Analysts and Investors for the Audited Financial Results of the Company for the Financial Year ended March 31, 2022 along with the fourth quarter results.",
            "news_id": "905fe3d2-c6fd-4b8c-a468-b6ab1a2737ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97e66575-1dc5-472a-94c1-06e9a208d52e.pdf",
            "news_date": "2022-05-27 16:57:45",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Conference call held today i.e. on Monday, May 23, 2022 on the Audited Financial Results of the Company for the fourth quarter and financial year ended March 31, 2022",
            "news_id": "0a634bed-63ea-4b5f-8f44-46b55d375458",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8987853-a34f-4501-9b50-e2a13bafd22f.pdf",
            "news_date": "2022-05-23 17:47:58",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the fourth quarter and financial year ended March 31, 2022",
            "news_id": "948a4c58-cb65-4750-a71d-294c3e646ec7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b938764a-674f-4938-bcb7-0a94c02e1f13.pdf",
            "news_date": "2022-05-20 14:43:25",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended March 31, 2022",
            "news_body": "Advanced Enzyme Technologies Limited has informed the Exchange about the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2022 along with the Auditor's Report issued by MSKA & Associates, Statutory Auditors of the Company<BR> <BR> The aforesaid financial results and other documents are also being uploaded on the website of the Company i.e. www.advancedenzymes.com<BR>",
            "news_id": "caae7416-c9fa-4862-8fcb-4d26f072c789",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea44dd0a-2a18-445a-be49-a3efb64bb991.pdf",
            "news_date": "2022-05-20 12:02:17",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On May 20, 2022",
            "news_body": "With reference to the Board meeting notice dated May 12, 2022, we hereby inform that the Board of Directors in its meeting held on May 20, 2022 (commenced at 11:00 a.m. and concluded at 11:45 a.m.) has inter-alia, transacted the following business :<BR> Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2022 along with the Auditor's Report issued by MSKA & Associates, Statutory Auditors of the Company.<BR> Recommended a Dividend @ 50% i.e. Rs. 1/- per equity share on the face value of Rs. 2/- each for the financial year ended March 31, 2022, subject to the approval of the Shareholders at the ensuing 33rd Annual General Meeting of the Company (''AGM'').<BR> Allotted 5,900 Equity Shares of face value of Rs. 2/- at an exercise price of Rs. 60/- per share pursuant to exercise of options under the Employees Stock Option Scheme, 2015.<BR> <BR> This is for your information and for public at large.<BR>",
            "news_id": "331ca44b-1779-49c3-ad13-e0cd949e5dfb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da872b9f-ec6e-43a6-957e-1b31f9e7ed96.pdf",
            "news_date": "2022-05-20 11:59:20",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimation letter dated February 03, 2022, please find enclosed the Transcript of the Conference call held on Tuesday, February 08, 2022 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter and nine months ended December 31, 2021",
            "news_id": "e38d69fe-5bff-47d7-84b4-4dd6dea24d57",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f0a1d71-4a8b-4a8f-9dcd-86481da3d973.pdf",
            "news_date": "2022-02-12 18:32:38",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter and nine months ended December 31, 2021",
            "news_id": "ae5b4c2b-4142-449a-8526-f91bd70fd8a3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7c7d146-a92d-4915-9192-601ce052ef05.pdf",
            "news_date": "2022-02-05 15:49:36",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31, 2021",
            "news_body": "Advanced Enzyme Technologies Limited has informed the Exchange about the Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2021 along with the Limited Review report issued by M S K A & Associates, Statutory Auditors of the Company.<BR> <BR> The aforesaid financial results along with Limited review report are also being uploaded on the website of the Company, i.e. www.advancedenzymes.com<BR>",
            "news_id": "aa176f02-0b36-4129-8636-a7a032030dae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=699153e7-639f-4dd4-9ada-f118e64bbe9e.pdf",
            "news_date": "2022-02-05 11:48:13",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "With reference to the Board meeting notice dated January 28, 2022, we hereby inform that the Board of Directors in its meeting held on February 05, 2022 (commenced at 10:55 a.m. and concluded at 11:30 a.m.) has inter-alia, approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter and nine months ended December 31, 2021.<BR> <BR> In view of the aforesaid, we hereby enclose the following:<BR> Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2021 along with the Limited Review Report issued by M S K A & Associates, Statutory Auditors of the Company.<BR> Allotted 9,200 Equity Shares of face value of Rs. 2/- at an exercise price of Rs. 60/- per share pursuant to exercise of options under the Employees Stock Option Scheme, 2015.<BR> <BR> This is for your information and for public at large.<BR>",
            "news_id": "326d648f-8075-46c7-8538-6be030d39f0b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32589664-6b37-4af8-816b-62fed65dcb73.pdf",
            "news_date": "2022-02-05 11:44:10",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimation letter dated October 28, 2021, please find enclosed the Transcript of the Conference call held on Wednesday, November 03, 2021 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter and half year ended September 30, 2021.",
            "news_id": "a54fa5df-6c0d-4037-be9d-d2be8b84fbdc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eef1628e-1e35-428a-9e43-4f9c0ccc2ae0.pdf",
            "news_date": "2021-11-08 18:27:39",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Revised Earnings Presentation for the quarter and half year ended September 30, 2021",
            "news_id": "0950efff-70b1-48d0-b3f7-3173d80a393b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0f6cdb8-c346-4de9-a2bb-bc312eb7e362.pdf",
            "news_date": "2021-11-02 18:05:44",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter and half year ended September 30, 2021",
            "news_id": "32c7a283-a6da-40f3-8ec3-6bc3fc109dea",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d0a753f-195a-4c16-82c0-90512f787ee3.pdf",
            "news_date": "2021-11-02 12:18:36",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "With reference to the Board meeting notice dated October 26, 2021, we hereby inform that the Board of Directors in its meeting held on November 02, 2021 (commenced at 10:49 a.m. and concluded at 11:35 a.m.) has inter-alia, approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter and half year ended September 30, 2021.<BR> <BR> In view of the aforesaid, we hereby enclose the following:<BR> Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2021 along with the Limited Review Report issued by M S K A & Associates, Statutory Auditors of the Company.<BR> Press Release and Earnings Presentation for the quarter and half year ended September 30, 2021.<BR> Allotted 13,175 Equity Shares of face value of Rs. 2/- at an exercise price of Rs. 60/- per share pursuant to exercise of options under the Employees Stock Option Scheme, 2015.<BR> <BR> This is for your information and for public at large.",
            "news_id": "90dc9a63-9c76-4a4e-b3b7-dc3001509211",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3b5df7f-2724-4df9-8e94-e820d1e0bc24.pdf",
            "news_date": "2021-11-02 12:05:40",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "Advanced Enzyme Technologies Limited has informed the Exchange about the Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2021 along with the Limited Review report issued by M S K A & Associates, Statutory Auditors of the Company.",
            "news_id": "375e15ec-42e6-4305-a8df-e692e35af789",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=efff69dc-b386-421c-83c4-8da09757849e.pdf",
            "news_date": "2021-11-02 12:02:54",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Further to the intimation dated September 28, 2021 and September 30, 2021, please find attached copy of the presentation as may be made by the Company at Motilal  Oswal Biotech and Medtech Day (virtual group meeting) scheduled to held today i.e. October 01, 2021",
            "news_id": "e95c4e95-358e-4b73-97eb-c022697ab6d1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8ca2877-3332-4be1-a68b-76cc42e3d1c2.pdf",
            "news_date": "2021-10-01 11:09:50",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimation letter dated August 08, 2021, please find enclosed the Transcript of the Conference call held on Wednesday, August 11, 2021 with Analysts and Investors for the un-audited Financial Results of the Company for the quarter ended June 30, 2021.",
            "news_id": "80c01ae3-b492-406d-b31a-04891aa3d8f1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=123eb446-ad51-4c96-b9b6-2750580ca2c5.pdf",
            "news_date": "2021-08-14 21:03:11",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter ended June 30, 2021",
            "news_id": "fed74805-fad7-4c1d-afad-6337425c4e2b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4726b7d9-76cf-460b-b1b0-52e57eb59d7d.pdf",
            "news_date": "2021-08-07 12:46:39",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2021",
            "news_body": "Advanced Enzyme Technologies Limited has informed the Exchange about the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2021 along with the Limited Review report issued by B S R & Co. LLP, Statutory Auditors of the Company.<BR> <BR> The aforesaid financial results along with Limited review report are also being uploaded on the website of the Company, i.e. www.advancedenzymes.com",
            "news_id": "a4db9b4b-d5b7-4547-8e1c-a3ce102beca8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb43b63d-3d8f-44ec-98ae-01568dacc270.pdf",
            "news_date": "2021-08-07 12:34:55",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "With reference to the Board meeting notice dated July 31, 2021, we hereby inform that the Board of Directors in its meeting held on August 07, 2021 has inter-alia, approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter ended June 30, 2021.<BR> <BR> In view of the aforesaid, we hereby enclose the following:<BR> Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2021 along with the Limited Review report issued by B S R & Co. LLP, Statutory Auditors of the Company as an Annexure.<BR> <BR> This is for your information and for public at large.",
            "news_id": "16e3a7c5-ba79-4af4-a1e5-2b56638194f1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a009e13-40c7-4037-8ad7-34999de77d54.pdf",
            "news_date": "2021-08-07 12:30:27",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI LODR') - Details Of Related Party Transactions On Consolidated Basis",
            "news_body": "Pursuant to the provisions of Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the relevant disclosure on Related Party Transactions (on consolidated basis) of the Company for the half year ended March 31, 2021.",
            "news_id": "c235a43f-d8cb-40b9-9b34-694bfa4203ab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f92a4ee3-55c3-4ee0-b7b3-7bc08afb388a.pdf",
            "news_date": "2021-06-24 18:35:50",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In furtherance to our intimation letter dated May 26, 2021, please find enclosed the Transcript of the Conference call held on Monday, May 31, 2021 with Analysts and Investors for the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2021.",
            "news_id": "95685673-6c62-4093-b558-29c8746bb474",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb4c8288-829f-435b-b5be-550df91a7ada.pdf",
            "news_date": "2021-06-03 17:53:27",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended March 31, 2021",
            "news_body": "The Company has informed the Exchange about the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2021.",
            "news_id": "2b01dfa7-80f4-4260-9acf-f4cd66296a08",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e811672c-ea60-479d-9194-25a7c51d3aff.pdf",
            "news_date": "2021-05-29 14:48:45",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On May 29, 2021",
            "news_body": "The Company has informed the Exchange about the Outcome of the Board Meeting held on May 29, 2021.",
            "news_id": "9463a94d-23f7-42ad-8e29-7611e224854f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6bd5912f-44dc-4c5c-a585-2e5f1bcd700d.pdf",
            "news_date": "2021-05-29 14:46:16",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call for Q3FY21 and 9MFY21",
            "news_id": "a7843a34-8ee8-4d24-8343-5b2c0dae2352",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a0a075a-e9de-4f36-a0df-921ef1accd5e.pdf",
            "news_date": "2021-02-21 22:09:54",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for the quarter and nine-months ended December 31, 2020",
            "news_id": "9c7a605c-d4bd-4f57-91e9-de42009ae9d2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3300969a-cd44-4cdb-85e0-9effa0fb47a7.pdf",
            "news_date": "2021-02-12 12:18:33",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31, 2020",
            "news_body": "Enclosed hereby are the Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine-months ended December 31, 2020 along with the Limited Review report issued by B S R & Co. LLP, Statutory Auditors of the Company.<BR> <BR> The aforesaid financial results along with Limited review report are also being uploaded on the website of the Company, i.e. www.advancedenzymes.com. This is for your information and for public at large.",
            "news_id": "508d3b12-ff57-4424-b3d8-6336fee31dfb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63e214d5-a22f-4f74-9a6f-16d4f410f5e3.pdf",
            "news_date": "2021-02-12 12:06:56",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ADVENZYMES",
            "disp": "Advanced Enzyme Tech",
            "bse_code": 540025,
            "isin": "INE837H01020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "With reference to the Board meeting notice dated February 02, 2021, we hereby inform that the Board of Directors in its meeting held on February 12, 2021 has inter-alia, approved the Unaudited Financial Results of the Company (Standalone & Consolidated) for the quarter and nine months ended December 31, 2020.<BR> <BR> In view of the aforesaid, we hereby enclose the following:<BR> Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2020 along with the Limited Review Report issued by B S R & Co. LLP, Statutory Auditors of the Company.<BR> Press Release and Earnings Presentation for the quarter and nine months ended December 31, 2020.<BR> Allotted 4,500 Equity Shares of face value of Rs. 2/- at an exercise price of Rs. 60/- per share pursuant to exercise of options under the Employees Stock Option Scheme, 2015.<BR> <BR> This is for your information and for public at large.",
            "news_id": "61ae5ad7-7dd3-4565-b986-ec2ec670ff9b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90b7fca5-2dd2-4041-9325-2a53365a3a50.pdf",
            "news_date": "2021-02-12 12:03:00",
            "seo": "advanced-enzyme-tech-ltd",
            "ltp": 311.2,
            "ch": 12.399999999999977,
            "pch": 4.149933065595708,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 18039,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}